Byong C. Yoo - Apr 30, 2025 Form 3 Insider Report for Liminatus Pharma, Inc. (LIMN)

Role: Chief Science Officer
Signature: /s/ Byong C. Yoo
Stock symbol: LIMN
Transactions as of: Apr 30, 2025
Transactions value $: $0
Form type: 3
Date filed: 4/30/2025, 07:12 PM
SEC: View on sec.gov

No securities are beneficially owned.